Toshiba's AIDR 3D Receives FDA Clearance

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

Toshiba America Medical Systems, Inc. has received FDA clearance of Adaptive Iterative Dose Reduction 3D (AIDR 3D), the company’s newest dose-reduction technology.

AIDR 3D is Toshiba’s third generation iterative dose reconstruction software that reduces radiation dose compared to conventional scanning. The algorithm is designed to work in both the raw data and image data space, reducing noise while attempting to maintain image quality.

AIDR 3D can also be seamlessly integrated with SUREExposureTM 3D, a software that calculates the minimum radiation exposure required for every exam. SUREExposure 3D adjusts the dose for each patient based on a preset, targeted level of image quality.

Toshiba says it will offer the AIDR 3D software upgrade and related training, complimentary, to all existing Aquilion™ ONE, Aquilion Premium and Aquilion PRIME CT customers.

View the press release for additional information.